In this issue:
- Prostate cancer mortality risk in men with PSA <3 ng/mL at screening
- New international recommendations for early-stage NSCLC
- NICE UK recommends rucaparib for BRCA-negative advanced ovarian cancer
- Refining the predictive model of prostate cancer using machine learning
- C-reactive protein levels predict bladder cancer outcomes
- New ASCO guidelines for neoadjuvant therapy in ovarian cancer
- Rethinking the somatic gene mutation paradigm of cancer pathogenesis
- Bladder sparing strategy may be feasible in some patients with muscle-invasive bladder cancer
- Regulatory News
- News in Brief
Please login below to download this issue (PDF)